A Greek diaspora scientist, Katerina Akasoglou, was elected a member of the National Academy of Inventors of the USA, an important distinction for her work, as it is the highest professional distinction in inventors from the academic field. Ms. Akasoglou is Professor of Neurology at the University of San Francisco (UCSF), Senior Fellow at the American Gladstones Institute, and Director of the Gladstone Center for Neurovascular Brain Immunology.
The Greek researcher studied Biology at the University of Athens, from where she also received a PhD in Neuroimmunology. She did postdoctoral research at the American universities of SUNY, Rockefeller and New York and was an assistant professor of Pharmacology at the University of California-San Diego, before moving to San Francisco and Gladstone.
It is considered a pioneer in studies on the mechanisms that control communication between the brain, the immune system and the vascular system, especially in diseases such as multiple sclerosis, Alzheimer's disease and other neurodegenerative diseases. Her research has shed light on the toxic role of blood proteins as they enter the brain, which has led to the development of new therapies for neurological diseases.
He has also developed sophisticated imaging tools and coordinated many international collaborations between universities and pharmaceutical companies, and as an inventor holds ten US patents with several biomedical applications. Among other things, he has invented an antibody that neutralizes the toxic effect of blood on neurodegenerative diseases. She is also the co-founder and director of the techno-germ company Therini Bio.
The official admission ceremony to the Academy, along with another 163 newly elected members, will take place in June 2022 in Phoenix, Arizona. Founded in 2010 to recognize and encourage innovation in the United States, the National Academy of Inventors has more than 4.000 members from 250 universities, research institutes, and other research institutes worldwide. Among other things, he publishes the magazine "Technology and Innovation".
Source: RES
Comments